Fatigue in cancer patients is not related to changes in oxyhaemoglobin dissociation

Supportive Care in Cancer

Volumn 13, Issue 10, 2005, Pages 854-858

  Stone, Patrick C ^a   Abdul Wahab, Alya ^a   Gibson, John S ^a   Wright, Rebecca J ^a   Andrews, Paul L ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; OXYGEN; OXYHEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER; CANCER PATIENT; CHEMICAL ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; DISSOCIATION; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HYPOTHESIS; MALE; OXYGEN TENSION; PRIORITY JOURNAL; QUESTIONNAIRE;

ADULT; AGED; AGED, 80 AND OVER; CONTROLLED CLINICAL TRIALS; FATIGUE; FEMALE; GREAT BRITAIN; HUMANS; HYDROGEN-ION CONCENTRATION; MALE; MIDDLE AGED; NEOPLASMS; OXYHEMOGLOBINS; QUESTIONNAIRES; STATE MEDICINE;

EID: 26244462507     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-005-0850-3     Document Type: Article

References (13)

1. Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer fatigue forum. Ann Oncol 11(8):971-975
2. Morrow GR, Andrews PL, Hickok JT, Roscoe JA, Matteson S (2002) Fatigue associated with cancer and its treatment. Support Care Cancer 10(5):389-398
3. Cella D, Lai JS, Chang CH, Peterman A, Slavin M (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528-538
4. Lind M, Vernon C, Cruickshank D, Wilkinson P, Littlewood T, Stuart N, Jenkinson C, Grey-Amante P, Doll H, Wild D (2002) The level of haemoglobin in anaemic cancer patients correlates positively with quality of life. Br J Cancer 86(8):1243-1249
5. Littlewood TJ, Bajetta E, Nortier JW, Vercammen E, Rapoport B, for the Epoetin Alfa Study Group (2001) Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial [comment]. J Clin Oncol 19(11):2865-2874
6. Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S (1997) Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. J Clin Oncol 15(3):1218-1234
7. Demetri G, Kris M, Wade J, Degos L, Cella D (1998) Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumour type: results from a prospective community oncology study. J Clin Oncol 16(10):3412-3425
8. Stone P, Richards M, A'Hern R, Hardy J (2000) A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol 11(5):561-567
9. Epstein CD, Henning RJ (1993) Oxygen transport variables in the identification and treatment of tissue hypoxia. Heart Lung 22(4):328-345; quiz 346-8
10. Mercuriali F, Inghilleri G (2001) Treatment of anaemia in cancer patients: transfusion of rHuEPO. In: Marty M, Pecorelli S (eds) Fatigue and cancer: European school of oncology scientific updates. Elsevier, Amsterdam, pp 185-200
11. Bron D (2001) Biological basis of cancer-related anaemia. In: Marty M, Pecorelli S (eds) Fatigue and cancer: European school of oncology scientific updates. Elsevier, Amsterdam, pp 45-50
12. Cella D (1997) The functional assessment of cancer therapy-anemia (FACT-An) scale: a new tool for the assessment of outcomes in cancer anemia and fatigue. Semin Hematol 34(3 Suppl 2):13-19
13. Tucker V (1967) Method for oxygen content and dissociation curves on microlitre blood samples. J Appl Physiol 23:410-414